Director, Investigations Branch, OPQO, ORA
U.S. FDA
Lieutenant Commander Jeffrey Meng is an engineer officer in the U.S. Public Health Service and currently serves as the Director of Investigations Branch for the Division of Pharmaceutical Quality Operations III within the ORA Office of Pharmaceutical Quality Operations. LCDR Meng leads a team of nearly 60 FDA pharmaceutical investigators, supervisors, and support staff conducting facility inspections and investigations throughout the US Midwest and internationally in support of FDA’s mission to provide safe and effective pharmaceuticals for the American public.
LCDR Meng began his FDA career in 2009 as an Investigator with advancing roles as a Drug Specialist and Supervisory Investigator prior to his current position as the Director of Investigations Branch while leveraging broad experiences including rotations to the FDA China Office in Shanghai and to the Center for Drug Evaluation and Research (CDER) within what is now the Office of Quality Surveillance (OQS). He continues to be heavily involved in major Agency initiatives such as the New Inspection Protocol Project, Compounding Center of Excellence, and the Pharmaceutical Investigator Course Advisory Group. LCDR Meng obtained his B.S.E. and M.S.E. in Biomedical Engineering from the University of Michigan.
Wednesday, September 29, 2021
12:35 – 13:15 EDT